SCHEMBL9515729

SCHEMBL9515729

O=CC(c1ccc(Cl)cc1)S(=O)(=O)NC(=O)c1ccc(COCc2ccccc2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 2/20 0.40
MCL1 Q07820 2/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
P4HTM Q9NXG6 3/20 0.38
CASP3 P42574 2/20 0.38
EGFR P00533 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CXCR2 P25025 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519628 0.92 BCL2L1 (0.42) BCL2L1MCL1NPC1RAB9AP4HTM
SCHEMBL9517937 0.89 EGFR (0.40) NPC1RAB9AP4HTMCASP3EGFR
SCHEMBL9516087 0.88 BCL2L1 (0.38) BCL2L1MCL1P4HTMCASP3CXCR2
SCHEMBL9517259 0.84 EGFR (0.39) P4HTMCASP3EGFRSMN1; SMN2SCN5A
SCHEMBL9516974 0.83 EGFR (0.44) NPC1RAB9AP4HTMCASP3EGFR
SCHEMBL9517165 0.83 VNN1 (0.40) BCL2L1MCL1SCN9AHDAC6
SCHEMBL9515738 0.82 P4HTM (0.43) BCL2L1MCL1NPC1RAB9AP4HTM
SCHEMBL9516990 0.80 P4HTM (0.37) P4HTMCASP3EGFRSCN5ASCN9A
SCHEMBL9517908 0.79 CXCR1 (0.39) P4HTMCASP3CXCR2HDAC6
SCHEMBL9517088 0.78 CXCR2 (0.38) BCL2L1MCL1P4HTMCASP3CXCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed